These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6295295)

  • 1. Mg++ antagonism of a prejunctional opiate receptor mediated effect at the frog neuromuscular junction.
    Durham HD; Frank GB
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):72-82. PubMed ID: 6295295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual action of meperidine on the frog neuromuscular junction: a prejunctional, opiate receptor-mediated depression of transmitter release and a postjunctional, nonopiate receptor effect on the endplate.
    Durham HD; Frank GB
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):150-65. PubMed ID: 6114716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of lead on neuromuscular junctions.
    Atchison WD; Narahashi T
    Neurotoxicology; 1984; 5(3):267-82. PubMed ID: 6097847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lead on neuromuscular transmission in the frog.
    Manalis RS; Cooper GP; Pomeroy SL
    Brain Res; 1984 Feb; 294(1):95-109. PubMed ID: 6320979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of trimethadione and its primary metabolite dimethadione on neuromuscular function and the effects of altered pH on the actions of dimethadione.
    Alderdice MT; McMillan JE
    J Pharmacol Exp Ther; 1982 Jun; 221(3):547-51. PubMed ID: 6283057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ammodytin L on miniature and endplate potentials in neuromuscular junction of frog m. cutaneus pectoris.
    Frangez R; Krizaj I; Gubensek F; Suput D
    Pflugers Arch; 2000; 440(5 Suppl):R101-2. PubMed ID: 11005629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic inhibition of quantal transmitter release from the magnesium-paralysed frog sartorius muscle.
    Arenson MS
    Neuroscience; 1989; 30(3):827-36. PubMed ID: 2788830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA; Molgó J; Lemeignan M; Lechat P
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of calcium currents and neurotransmitter release by barium ions at frog motor nerve endings.
    Silinsky EM
    Br J Pharmacol; 2000 Jan; 129(2):360-6. PubMed ID: 10694243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thiol-oxidizing agent diamide increases transmitter release by decreasing calcium requirements for neuromuscular transmission in the frog.
    Carlen PL; Kosower EM; Werman R
    Brain Res; 1976 Nov; 117(2):257-76. PubMed ID: 186154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple actions of beta-bungarotoxin on acetylcholine release at amphibian motor nerve terminals.
    Alderdice MT; Volle RL
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr; 316(2):126-30. PubMed ID: 6972488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in MEPP frequency during depression of evoked release at the frog neuromuscular junction.
    Zengel JE; Sosa MA
    J Physiol; 1994 Jun; 477(Pt 2):267-77. PubMed ID: 7932218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of carbachol and alpha-bungarotoxin on the frequency of miniature endplate potentials at the frog neuromuscular junction.
    Bukharaeva E; Ipatova T; Nikolsky EE; Vyskocil F
    Exp Physiol; 2000 Mar; 85(2):125-31. PubMed ID: 10751508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of emetine and dehydroemetine at the frog neuromuscular junction.
    Alkadhi KA
    Eur J Pharmacol; 1987 Jun; 138(2):257-64. PubMed ID: 2887439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of spontaneous and evoked release of acetylcholine during dithiobiuret-induced neuromuscular weakness.
    Atchison WD
    J Pharmacol Exp Ther; 1989 Jun; 249(3):735-43. PubMed ID: 2499675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tetrandrine on spontaneous and evoked release of acetylcholine at the mouse neuromuscular junction.
    Wiegand H; McIntosh LJ; Gotzsch U; Krämer U
    J Pharmacol Exp Ther; 1996 Nov; 279(2):891-901. PubMed ID: 8930197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primidone but not phenylethylmalonamide, a major metabolite, increases nerve-evoked transmitter release at the frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1982 Jul; 222(1):87-93. PubMed ID: 6123595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative patterns of tubocurarine action on the synaptic potentials of frog muscle].
    Grigor'ev VM; Danilov AF; Skliarov AI
    Fiziol Zh SSSR Im I M Sechenova; 1988 Sep; 74(9):1228-34. PubMed ID: 2850942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aminoglycoside antibiotics on the neuromuscular junction: Part I.
    Yamada S; Kuno Y; Iwanaga H
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):130-8. PubMed ID: 3699939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.